Impel NeuroPharma Receives $36,000,000 Series C Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=40f6d690-600d-4f30-8e9e-a1392c6a07de - Date
12/6/2016 - Company Name
Impel NeuroPharma - Mailing Address
915 East Pine Street Seattle, WA 98122 USA - Company Description
Seattle-based Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier. - Website
http://www.impelneuropharma.com - Transaction Type
Venture Equity - Transaction Amount
$36,000,000 - Transaction Round
Series C - Proceeds Purposes
The company will use the proceeds to advance its drug delivery platform. - M&A Terms
- Venture Investor
venBio - Venture Investor
5AM Ventures - Venture Investor
Vivo Capital
